Clinical Trial Update: Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of low-dose/metronomic chemotherapy for metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Chemotherapy, Breast Cancer, Metastatic | Phase 2 | Status: TERMINATED